AP: U.K. stocks up on vaccines, hopes to start virus shots in days (Lawless, 11/29).

DW: Coronavirus digest: Britain names COVID vaccine minister (11/28).

DW: Coronavirus vaccine — how to distribute it around the world? (Zivkovic, 11/27).

Financial Times: International rollout of Covid-19 vaccine on track for next month (Mancini et al., 11/29).

Financial Times: Covid vaccines offer Big Pharma a chance of rehabilitation (Neville/Kuchler, 11/27).

Fortune: Pfizer’s COVID vaccine comes with a chilly complication. But that may change (Morris, 11/28).

The Guardian: China hopes ‘vaccine diplomacy’ will restore its image and boost its influence (Graham-Harrison/Phillips, 11/28).

The Hill: First doses of Pfizer coronavirus vaccine have flown to U.S. from Belgium: report (Deese, 11/28).

The Hill: U.K. to approve Pfizer and BioNTech COVID-19 vaccine next week: report (Williams, 11/28).

KHN: How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID (Pradhan, 11/30).

STAT: Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom (Branswell, 11/30).

The Telegraph: Divisions emerge among U.S. officials over when first Covid-19 vaccine doses will be available — and for whom (Hargreaves, 11/28).

U.N. News: COVID-19: Testing still vital even as vaccines roll out (11/27).

U.N. News: African nations ‘far from ready’ for COVID-19 vaccination drive, says U.N. health agency (11/27).

Wall Street Journal: Covid-19 Vaccine Studies May Suffer as Volunteers Consider Dropping Out (Winkler et al., 11/27).